NORWOOD SYSTEMS LTD/ AU000000NOR1 /
2024-04-17 8:10:49 AM | Chg. 0.0000 | Volume | Bid10:14:55 AM | Ask10:14:55 AM | High | Low |
---|---|---|---|---|---|---|
0.0240EUR | 0.00% | 0 Turnover: 0.0000 |
0.0240Bid Size: 125,000 | 0.0340Ask Size: 89,000 | 0.0240 | 0.0240 |
GlobeNewswire
04-11
MariMed Closes Acquisition of Thrive Dispensary in Casey, The Company’s Fifth Illinois Dispensary
GlobeNewswire
04-02
Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Necti...
GlobeNewswire
03-12
Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corpo...
GlobeNewswire
03-12
A Bigger Dispensary Opens in the Town of “Big Things” as MariMed Opens Larger, Permanent Thrive Disp...
GlobeNewswire
03-06
Corbus Pharmaceuticals to Participate in the BMO Capital Markets Inaugural Obesity Summit
GlobeNewswire
03-04
MariMed’s Betty’s Eddies™ Introduces Ache Away Eddies PM For Those Who Chews A Pain-Free Night’s Sle...
GlobeNewswire
02-29
MariMed Introduces New and Improved Vibations™ Cannabis and Electrolyte Drink Mix
GlobeNewswire
02-06
Corbus Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
GlobeNewswire
02-02
Corbus Pharmaceuticals Announces Closing of $94.5 Million Public Offering of Common Stock including ...
GlobeNewswire
01-29
Norwood Financial Corp Announces Earnings for the Fourth Quarter and 2023 Fiscal Year
GlobeNewswire
01-26
CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting Antibody Drug Conjugate Demonstrates Encourag...
GlobeNewswire
01-18
MariMed Brands Take Top Honors At Major Cannabis Awards Shows In Massachusetts and Maryland
GlobeNewswire
01-09
Corbus Pharmaceuticals Announces FDA Clearance of IND Application for its anti-αvβ8 monoclonal antib...
GlobeNewswire
2023-12-18
Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO GU